Business Venture

Jim Tananbaum’s Unique Entrepreneurial Path in the Health Care Sector of the United States

Jim Tananbaum started a unique business that caters to the health of patients by improving the kind of services they receive. Foresite Capital identifies and backs rising and promising innovators in health care by providing networks, funds, and information. Presently, the firm’s biggest investment involves supporting diabetes patients manage their condition and lose weight through the solutions offered by Intarcia. Intarcia’s products are speculated to have an effect equal in power to the IUDs which are famous for birth control. Jim stated that the launch of the product would help the recovery of millions among the 350 million people diagnosed with diabetes across the globe. Visit Forbes to know more.

Jim has built an empire business by relying on the expertise and knowledge of intelligent and experienced leaders in health care. Additionally, he spends most of his time updating his knowledge on emerging technologies in medicine. Jim revealed that he has a passion for learning new things which always puts him ahead of the curve. He acquired an engineering and computer science major from the University of Yale, an MD and an MBA from Harvard University, and an MS from MIT. He has an innate curiosity about the connection between health care and computer science and inclined his career in the niche. Jim Tananbaum has seasoned mentors and collaborators who have seen him through his journeys, such as Rick Levin of Yale, George Whitesides of Harvard, Rick Klausner of NCI, Gunderson Detmer, and Roy Vagelos. In collaboration with these academicians and entrepreneurs, Jim has the vision to revolutionize health care by developing fast and efficient innovations to replace the predecessors or begin operating a new field of medicine. You can visit Ideamensch to know more.

Jim’s journey in innovation was not a smooth ride from conception. In 2009, he had the opportunity of investing in a couple of promising health care companies but was not able to because of partners who did not have permission to disperse funds. In 2010, Jim excluded himself from the firm in hopes of raising enough cash to invest. Unfortunately, 99 percent of his prospective targets turned down his first attempts. Jim’s persistence and vision have enabled him to find opportunities in 77 healthcare firms including leaders such as Aeri Pharmaceuticals, 10X, Sequenta, Nanostring, Intellia, Muse Bio, Editas, HealthyVerity, and Mindstrong.

Check out the website

 Click here: